1. ZnO Nanowire Arrays Exhibit Cytotoxic Distinction to Cancer Cells with Different Surface Charge Density: Cytotoxicity is Charge‐Dependent
   Ruizhi Ning et al, 2014, Small CrossRef
2. Pristimerin, a triterpene that inhibits monoacylglycerol lipase activity, prevents the development of paclitaxel-induced allodynia in mice
   Altaf Al-Romaiyan et al, 2022, Frontiers in Pharmacology CrossRef
3. Potential role of S100A8 in skin rejuvenation with the 1064-nm Q-switched Nd:YAG laser
   Yan Qin et al, 2018, Lasers in Medical Science CrossRef
4. Investigation of Cytotoxic and Apoptogenic Effects of Terminalia Chebula Hydro-Alcoholic Extract on Glioblastoma Cell Line
   Amir Reza Afshari et al, 2018, The Neuroscience Journal of Shefaye Khatam CrossRef
5. Synthesis and bio-physical characterization of Silver nanoparticle and Ag-mesoporous MnO2 nanocomposite for anti-microbial and anti-cancer activity
   Jothi Ramalingam R. et al, 2017, Journal of Molecular Liquids CrossRef
6. Pristimerin exhibits anti-cancer activity by inducing ER stress and AKT/GSK3β pathway through increasing intracellular ROS production in human esophageal cancer cells
   Wei-Bin Hu et al, 2024, Toxicology in Vitro CrossRef
7. Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
   Run-Ze Chen et al, 2021, Frontiers in Oncology CrossRef
8. In vitro and in vivo anti-leukemia activity of the stem bark of Salacia impressifolia (Miers) A. C. Smith (Celastraceae)
   Ana Carolina B. da C. Rodrigues et al, 2019, Journal of Ethnopharmacology CrossRef
9. The cap-translation inhibitor 4EGI-1 induces mitochondrial dysfunction via regulation of mitochondrial dynamic proteins in human glioma U251 cells
   Xin Yang et al, 2015, Neurochemistry International CrossRef
10. Development and Validation of an HPLC-PDA Method for Biologically Active Quinonemethide Triterpenoids Isolated from Maytenus chiapensis
    Vito Taddeo et al, 2019, Medicines CrossRef
11. ATTEMPTS TO SYNTHESIZE A TRIMERIC DERIVATIVE OF PRISTIMERIN WITH POTENTIAL ACTIVITY AGAINST CANCER CELLS
    Josana Pereira Dos Santos et al, 2024, Revista Contemporânea CrossRef
12. Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling
    GUI'E XIE et al, 2016, Oncology Letters CrossRef
13. Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
    Jia-jun Li et al, 2019, Frontiers in Pharmacology CrossRef
14. Dracorhodin perchlorate induces the apoptosis of glioma cells
    XIN CHEN et al, 2016, Oncology Reports CrossRef
15. The Anti-Lung Cancer Activities of Steroidal Saponins of P. polyphylla Smith var. chinensis (Franch.) Hara through Enhanced Immunostimulation in Experimental Lewis Tumor-Bearing C57BL/6 Mice and Induction of Apoptosis in the A549 Cell Line
    Yu Li et al, 2013, Molecules CrossRef
16. Pristimerin triggers AIF-dependent programmed necrosis in glioma cells via activation of JNK
    Hongwei Zhao et al, 2016, Cancer Letters CrossRef
17. A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer
    Buse Cevatemre et al, 2018, Pharmacological Research CrossRef
18. Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells
    Yingbing Zhang et al, 2019, International Journal of Molecular Medicine CrossRef
19. Determination of IC50 values of anticancer drugs on cells by D2O – single cell Raman spectroscopy
    Wanxue Lv et al, 2022, Chemical Communications CrossRef
20. Mechanisms of proteasome inhibitor-induced cytotoxicity in malignant glioma
    Panagiotis J. Vlachostergios et al, 2013, Cell Biology and Toxicology CrossRef
21. Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
    Elaine C. D. Gonçalves et al, 2020, Molecules CrossRef
22. Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of apoptosis in prostate cancer cells by pristimerin
    YONG BO LIU et al, 2014, International Journal of Oncology CrossRef
23. Pristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cells
    Bashir A. Yousef et al, 2016, Biomedicine & Pharmacotherapy CrossRef
24. Pristimerin in Oxidative Stress and Use in Cancer
    Ana Carolina B. da C. Rodrigues et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
25. Pristimerin improve renal fibrosis by regulating miRNA-145-5p in vitro and vivo study
    Chen XIAO-MEI et al, 2022, Food Science and Technology CrossRef
26. Appraisal of Medicinal Plants with Anticancer Properties in South America
    Alírica Isabel Suárez et al, 2018, Anticancer plants: Properties and Application CrossRef
27. Analysis of signaling cascades from myeloma cells treated with pristimerin
    Heba Almaghrbi et al, 2023, Regulation of Downstream Targets CrossRef
28. Development and validation of a quantitative liquid chromatography tandem mass spectrometry assay for pristimerin in rat plasma
    Xin Luan et al, 2013, Journal of Chromatography B CrossRef
29. Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins
    BASHIR A. YOUSEF et al, 2016, Oncology Reports CrossRef
30. Cis-3-O-p-hydroxycinnamoyl Ursolic Acid Induced ROS-Dependent p53-Mediated Mitochondrial Apoptosis in Oral Cancer Cells
    Ching-Ying Wang et al, 2019, Biomolecules & Therapeutics CrossRef
31. Pristimerin‐induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway
    Fengxia Yan et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
32. Anticancer Potential and Molecular Targets of Pristimerin in Human Malignancies
    Kirti Prabhu et al, 2024, Pharmaceuticals CrossRef
33. Pristimerin in Oxidative Stress and Use in Cancer
    Ana Carolina B. da C. Rodrigues et al, 2021, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
34. Inhibition of hTERT in pancreatic cancer cells by pristimerin involves suppression of epigenetic regulators of gene transcription
    Dorrah Deeb et al, 2017, Oncology Reports CrossRef
35. Natural products in suppressing glioma progression: A focus on the role of microRNAs
    Peyman Tabnak et al, 2022, Phytotherapy Research CrossRef
36. Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2
    DORRAH DEEB et al, 2014, International Journal of Oncology CrossRef
37. Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells
    DORRAH DEEB et al, 2015, Oncology Reports CrossRef
38. Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression
    Xianbing Peng et al, 2015, Cancer Chemotherapy and Pharmacology CrossRef
39. Plant-Derived Prooxidants as Potential Anticancer Therapeutics
    Alak Manna et al, 2016, CrossRef
40. Mitochondrial pathway is involved in the protective effects of alpha-ketoglutarate on hydrogen peroxide induced damage to intestinal cells
    Qian Jiang et al, 2017, Oncotarget CrossRef
41. Oleanolic acid derivatives induce apoptosis in human leukemia K562 cell involved in inhibition of both Akt1 translocation and pAkt1 expression
    Shuhua Pan et al, 2015, Cytotechnology CrossRef
42. Pristimerin induces apoptosis of oral squamous cell carcinoma cells via G1 phase arrest and MAPK/Erk1/2 and Akt signaling inhibition
    Haiyan Wu et al, 2019, Oncology Letters CrossRef
43. The Inhibitory Effects of Phenolic and Terpenoid Compounds from Baccharis trimera in Siha Cells: Differences in Their Activity and Mechanism of Action
    Cristiane De Oliveira et al, 2013, Molecules CrossRef
44. Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-кB signaling pathway in colorectal cancer cells
    Bashir A. Yousef et al, 2018, Phytomedicine CrossRef
45. Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways
    Xuedong Li et al, 2021, Drug Design, Development and Therapy CrossRef
46. Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells
    Seon-Ok Lee et al, 2016, BMC Cancer CrossRef